Cargando…

GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells

Clinical studies have shown that Selank had an anxiolytic effect comparable to that of classical benzodiazepine drugs, which can enhance the inhibitory effect of GABA by allosteric modulation of GABA(A) receptors. These data suggest that the molecular mechanism of the effect of Selank may also be re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Filatova, Elena, Kasian, Anastasiya, Kolomin, Timur, Rybalkina, Ekaterina, Alieva, Anelya, Andreeva, Lyudmila, Limborska, Svetlana, Myasoedov, Nikolay, Pavlova, Galina, Slominsky, Petr, Shadrina, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328971/ https://www.ncbi.nlm.nih.gov/pubmed/28293190 http://dx.doi.org/10.3389/fphar.2017.00089

Ejemplares similares

Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission
por: Volkova, Anastasiya, et al.
Publicado: (2016)

Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats
por: Kasian, Anastasiya, et al.
Publicado: (2017)

Involvement of Endocytosis and Alternative Splicing in the Formation of the Pathological Process in the Early Stages of Parkinson's Disease
por: Alieva, Anelya Kh., et al.
Publicado: (2014)

Housekeeping Genes for Parkinson’s Disease in Humans and Mice
por: Alieva, Anelya Kh., et al.
Publicado: (2021)

Potential Biomarkers of the Earliest Clinical Stages of Parkinson's Disease
por: Alieva, Anelya Kh., et al.
Publicado: (2015)

Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain
por: Weston-Green, Katrina, et al.
Publicado: (2012)

VCP expression decrease as a biomarker of preclinical and early clinical stages of Parkinson’s disease
por: Alieva, Anelya, et al.
Publicado: (2020)

Expression Analysis of Genes Involved in Transport Processes in Mice with MPTP-Induced Model of Parkinson’s Disease
por: Rudenok, Margarita M., et al.
Publicado: (2022)

Implications of GABAergic Neurotransmission in Alzheimer’s Disease
por: Li, Yanfang, et al.
Publicado: (2016)

Differential expression of Dusp1 and immediate early response genes in the hippocampus of rats, subjected to forced swim test
por: Vlasov, Ivan, et al.
Publicado: (2023)

Transcriptome Profiling Reveals Differential Expression of Circadian Behavior Genes in Peripheral Blood of Monozygotic Twins Discordant for Parkinson’s Disease
por: Semenova, Ekaterina I., et al.
Publicado: (2022)

Major Depression: One Brain, One Disease, One Set of Intertwined Processes
por: Filatova, Elena V., et al.
Publicado: (2021)

Amyloid Precursor Protein (APP) and GABAergic Neurotransmission
por: Tang, Bor Luen
Publicado: (2019)

GABAergic Neurotransmission in Human Tissues Is Modulated by Cannabidiol
por: Ruffolo, Gabriele, et al.
Publicado: (2022)

Whole-Transcriptome Analysis of Dermal Fibroblasts, Derived from Three Pairs of Monozygotic Twins, Discordant for Parkinson’s Disease
por: Alieva, Anelya Kh., et al.
Publicado: (2019)

Influence of glutamatergic and GABAergic neurotransmission on obstructive sleep apnea
por: Kaczmarski, Piotr, et al.
Publicado: (2023)

Angiotensin-II Modulates GABAergic Neurotransmission in the Mouse Substantia Nigra
por: Singh, Maibam R., et al.
Publicado: (2021)

Neuroprotective Peptides and New Strategies for Ischemic Stroke Drug Discoveries
por: Dergunova, Lyudmila V., et al.
Publicado: (2023)

Extrasynaptic and Postsynaptic Receptors in Glycinergic and GABAergic Neurotransmission: A Division of Labor?
por: Muller, Emilie, et al.
Publicado: (2008)

Microglial Morphology and Dynamic Behavior Is Regulated by Ionotropic Glutamatergic and GABAergic Neurotransmission
por: Fontainhas, Aurora M., et al.
Publicado: (2011)

PD-1 Regulates GABAergic Neurotransmission and GABA-Mediated Analgesia and Anesthesia
por: Jiang, Changyu, et al.
Publicado: (2020)

Modulation of Hippocampal GABAergic Neurotransmission and Gephyrin Levels by Dihydromyricetin Improves Anxiety
por: Silva, Joshua, et al.
Publicado: (2020)

Epigenetic Regulation of GABAergic Neurotransmission and Neurosteroid Biosynthesis in Alcohol Use Disorder
por: Gatta, Eleonora, et al.
Publicado: (2020)

Presynaptic Glycine Receptors Increase GABAergic Neurotransmission in Rat Periaqueductal Gray Neurons
por: Choi, Kwi-Hyung, et al.
Publicado: (2013)

Involvement of GABAergic and Adrenergic Neurotransmissions on Paraventricular Nucleus of Hypothalamus in the Control of Cardiac Function
por: Mendonça, Michelle M., et al.
Publicado: (2018)

Cortical cells reveal APP as a new player in the regulation of GABAergic neurotransmission
por: Doshina, Anna, et al.
Publicado: (2017)

Cellular and molecular signatures of in vivo imaging measures of GABAergic neurotransmission in the human brain
por: Lukow, Paulina Barbara, et al.
Publicado: (2022)

Modeling Parkinson’s Disease: Not Only Rodents?
por: Shadrina, Maria, et al.
Publicado: (2021)

The Glutamine Transporter Slc38a1 Regulates GABAergic Neurotransmission and Synaptic Plasticity
por: Qureshi, Tayyaba, et al.
Publicado: (2019)

Contribution of Smoothened Receptor Signaling in GABAergic Neurotransmission and Chloride Homeostasis in the Developing Rodent Brain
por: Hamze, Mira, et al.
Publicado: (2021)

Insight into Glyproline Peptides’ Activity through the Modulation of the Inflammatory and Neurosignaling Genetic Response Following Cerebral Ischemia–Reperfusion
por: Stavchansky, Vasily V., et al.
Publicado: (2022)

Whole-Exome Sequencing in Searching for New Variants Associated With the Development of Parkinson’s Disease
por: Shulskaya, Marina V., et al.
Publicado: (2018)

GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer’s disease
por: Nava-Mesa, Mauricio O., et al.
Publicado: (2014)

Crosstalk Between GABAergic Neurotransmission and Inflammatory Cascades in the Post-ischemic Brain: Relevance for Stroke Recovery
por: Michalettos, Georgios, et al.
Publicado: (2022)

Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1–12 dosage
por: Shadrina, Maria I, et al.
Publicado: (2007)

A quaternary equation for interdisciplinary medical research (IMR)
por: Shuman, Marc, et al.
Publicado: (2012)

Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
por: Filatova, Elena V., et al.
Publicado: (2021)

Analysis of ADORA2A, MTA1, PTGDS, PTGS2, NSF, and HNMT Gene Expression Levels in Peripheral Blood of Patients with Early Stages of Parkinson's Disease
por: Semenova, Ekaterina I., et al.
Publicado: (2023)

Transcriptome Analysis of Induced Pluripotent Stem Cells and Neuronal Progenitor Cells, Derived from Discordant Monozygotic Twins with Parkinson’s Disease
por: Vlasov, Ivan N., et al.
Publicado: (2021)

Inhibition of GABAergic Neurotransmission by HIV-1 Tat and Opioid Treatment in the Striatum Involves μ-Opioid Receptors
por: Xu, Changqing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1tlbuoiu6jck7e7r75e64lj6da